Abiopharma

CONSTRUCTION PARTNERS, INC. (ROAD) Announces Regulatory Update CONSTRUCTION PARTNERS, INC. (ROAD) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: • Applications: BLA (Biologics License Application) • Regulatory Agencies: EMA (European Medicines Agency) • Status: Extended Review Clinical Development:

• targeting,” “could,” “might,” “may,” “will,” “expect,” “should,” “anticipate,” “intend,” “project,” “outlook,” “believe,” “plan” and similar expressions or their negative. These and other forward-looking statements are based on management’s current views and assumptions and involve risks and uncertainties that could significantly affect expected results. Important factors that could cause actual results to differ materially from those expressed in the forward-looking statements are set forth in the Company’s most recent Annual Report on Form 10-K, its subsequent Quarterly Reports on Form 10-Q, its Current Reports on Form 8-K and other reports the Company files with the SEC. Forward-looking statements speak only as of the date they are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events, or circumstances or other changes affecting such statements except to the extent required by applicable law.Contact:Rick Black / Ken DennardDennard Lascar Investor RelationsROAD@DennardLascar.com(713) 529-6600